Search

everythinglearnresearchcommunity

for

Search:↓

Isotretinoin improves severe acne without changing androgen or insulin levels but may increase body weight and triglycerides.

Severe vertex pattern hair loss may indicate a higher risk for artery plaque buildup.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

PCOS affects women's health by increasing the risk of diabetes, heart disease, and reproductive issues.

Early treatment of PCOS in teens is crucial to prevent long-term health issues like diabetes and heart disease.

Early hair whitening may indicate a higher risk of heart disease in young and middle-aged men.

Cordyceps militaris is a promising, cost-effective medicinal fungus with health benefits and efficient production methods.

Wheat straw is valuable for its health benefits and various industrial uses.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

Women with PCOS have more body fat and thicker fat layers in certain abdominal areas than women without PCOS.

Hair loss may signal metabolic problems and increased risk of heart disease, suggesting people with hair loss should be checked for these issues.

Mild essential fatty acid deficiency can cause health issues and is worsened by low-fat diets.

Young men with early hair loss have slightly worse blood sugar and fat levels, suggesting possible health risks and need for monitoring.

Obese Hispanic women with PCOS are at higher risk for metabolic problems than non-Hispanic white women.

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.

Rosuvastatin improves lipid levels, reduces inflammation, but worsens insulin sensitivity in men with early-onset hair loss.

Different types of PCOS have different levels of metabolic problems, with the most severe type showing the highest disturbances.

Statins may help treat PCOS by lowering androgen levels and improving cholesterol.

Obesity in the U.S. is largely influenced by diet and exercise, certain medications can improve heart procedures and hair growth, and major teaching hospitals have better patient outcomes.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

The research found that anovulatory young women have higher androgen and hormone levels than those who ovulate, suggesting immature hormonal regulation rather than a specific condition.

Finasteride effectively treats hair loss and enlarged prostate in men, with mild side effects.

Men with benign prostatic hyperplasia are more likely to have metabolic syndrome than those without it.

In Japan, sex reassignment surgery for gender identity disorder faces challenges and needs better medical support and education.

The French Endocrine Society suggests diagnosing PCOS with two of three signs, recommends lifestyle changes and clomiphene for treatment, and calls for more research on certain treatments and tests.

The conclusions are: fecal short-chain fatty acids may help prevent cancer, fiber intake can reduce obesity, weight loss is hard for obese people, low BMI cancer patients are more prone to chemotherapy side effects, intermittent fasting benefits gut health, cherry laurel has health benefits in rats, certain gene variations can increase stress in hair loss patients, fecal acids can affect blood sugar levels, cold agglutinin can affect blood test results in autoimmune patients, and people with Crohn's disease have higher levels of a certain chemical in their blood.

Metabolic syndrome and PCOS are related but separate conditions, with metabolic syndrome increasing the risk of heart disease and diabetes.

Women with PCOS often have liver disease, so liver health checks are important for them.

Young women with PCOS have a higher risk of high blood pressure and metabolic syndrome, but these risks may decrease after age 40.

The enzyme myo-inositol oxygenase is not linked to the cause of polycystic ovarian syndrome.